Evofem Reports Fifth Consecutive Year of Net Sales Growth
EVOFEM BIOSCIENCE INC (EVFM)
Last evofem bioscience inc earnings: 3/12 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
evofem.com
Company Research
Source: Business Wire
— Net sales surpassed $20 million mark in FY 2025 —— Income from operations increased to $3.4 million in FY 2025 — SAN DIEGO--(BUSINESS WIRE)--Women’s health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the fourth quarter and year ended December 31, 2025. Highlights include:Achieved record net sales of $20.2 million in 2025—Evofem’s fifth consecutive year of net sales growth—mainly driven by sales of PHEXX® (lactic acid, citric acid, and potassium bitartrate), our hormone-free, on demand contraceptive vaginal gel.Reduced total operating expenses by 38% to $16.8 million in 2025 versus $27.0 million in 2024. The $10.2 million reduction included a $ 5.6 million gain from the settlement of a portion of the Company’s trade payables with vendors, and a $1.9 million non-cash gain on the change in accounting estimates on a contingent royalty liability.Income from operations increased to $3.4 million in 2025, versus a loss f
Show less
Read more
Impact Snapshot
Event Time:
EVFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVFM alerts
High impacting EVOFEM BIOSCIENCE INC news events
Weekly update
A roundup of the hottest topics
EVFM
News
- Evofem Reports Fifth Consecutive Year of Net Sales Growth [Yahoo! Finance]Yahoo! Finance
- Evofem CEO Saundra Pelletier Calls for a "Ground-Up Reset" of Women's Health at Fierce JPM Week 2026 [Yahoo! Finance]Yahoo! Finance
- Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women’s Health at Fierce JPM Week 2026Business Wire
- Evofem Expands "Say Vagina" Campaign With Launch of Say Vagina Store [Yahoo! Finance]Yahoo! Finance
- Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina StoreBusiness Wire
EVFM
Sec Filings
- 3/19/26 - Form 8-K
- 3/11/26 - Form 8-K
- 3/11/26 - Form 10-K
- EVFM's page on the SEC website